Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

ACR2022 - Day 3.1

ACR2022 - Day 3.1

FromRheumnow Podcast


ACR2022 - Day 3.1

FromRheumnow Podcast

ratings:
Length:
23 minutes
Released:
Nov 14, 2022
Format:
Podcast episode

Description

Comorbidities in Axial Spondyloarthritis
Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence.
Diffuse alveolar hemorrhage in antiphospholipid syndrome
Dr. Eric Dein discusses Abstract 0675 at ACR22 Convergence.
Abstract 0675: Clinical Characteristics and Factors Associated with Relapse and Mortality in Diffuse Alveolar Hemorrhage Among Patients with Antiphospholipid Syndrome: A Multi-Center Retrospective Cohort
Eosinophilia in systemic JIA patients after exposure to biologics
Dr. Bella Mehta discusses Abstract 0872 at ACR22 Convergence.
Abstract 0872: Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis
Gender differences in Axial Spondyloarthritis
Dr. Antoni Chan covered abstracts 0497 and 1614 at ACR22 Convergence in Philadelphia, PA.
Inadequate Dosing of Hydroxychloroquine Leads to Hospitalizations in SLE
Dr. Sheila Reyes discusses abstract 1654 at ACR22 Convergence. 
Abstract 1654: Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares
Oligoarticular PsA: FOREMOST Study
Dr. Peter Nash discusses abstract 1018 at ACR22 Convergence. 
Abstract 1018: Characterization of Joint Distribution and Disease Burden in Patients with Early Oligoarticular Psoriatic Arthritis: Results from the Ongoing FOREMOST Study
Sensor-engineered glove evaluates hand function in RA
Dr. David Liew discusses abstract 0904 at ACR22 Convergence. 
Abstract 0904: Testing the Hand Function with a Sensor-engineered Glove in Patients with Rheumatoid Arthritis
Released:
Nov 14, 2022
Format:
Podcast episode

Titles in the series (100)

Dr Jack Cush reviews the news, journal reports and FDA approvals